Uptake and distribution of fullerenes in human mast cells

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 4, 2010, Pages 575-582

  Dellinger, Anthony ^a   Zhou, Zhiguo ^a   Norton, Sarah K ^b   Lenk, Robert ^a   Conrad, Daniel ^b   Kepley, Christopher L ^a  

^a LUNA INNOVATIONS INC   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Fullerene; Intracellular trafficking; Mast cell; Nanomedicine

Indexed keywords

ALLERGIC INFLAMMATION; CARBON CAGES; CELLULAR INHIBITORS; ENDOPLASMIC RETICULUM; HUMAN MAST CELLS; IN-SITU; IN-VITRO; INTRACELLULAR TRAFFICKING; MAST CELLS; NANOMEDICINE; NANOMEDICINES; POTENT INHIBITOR; REACTIVE OXYGEN SPECIES; SECRETORY GRANULES; SIDE CHAINS; THERAPEUTIC AGENTS; TIME COURSE;

CAGES (MINE HOISTS); CALCIUM; CONFOCAL MICROSCOPY; CYTOLOGY; MEDICAL NANOTECHNOLOGY; OXYGEN; PATHOLOGY;

FULLERENES;

ANTIINFLAMMATORY AGENT; CALCIUM; FULLERENE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INTRACELLULAR TRANSPORT; LYSOSOME; MAST CELL; MITOCHONDRION; NANOMEDICINE;

CELL NUCLEUS; ENDOCYTOSIS; FULLERENES; HUMANS; MAST CELLS; MICROSCOPY, CONFOCAL; REACTIVE OXYGEN SPECIES;

EID: 77955271787     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2010.01.008     Document Type: Article

References (26)

1. Wilson S.R., Schuster D.I., Nuber B., Meier M., Prato M., Taylor R. Fullerenes: chemistry, physics, and technology 2000, 437-466. John Wiley & Sons, New York. K. Kadish, R. Ruoff (Eds.).
2. Ryan J.J., Bateman H.R., Stover A., Gomez G., Norton S.K., Zhao W., et al. Fullerene nanomaterials inhibit the allergic response. J Immunol 2007, 179:665-672.
3. Dellinger A., Zhou Z., Lenk R., MacFarland D., Kepley C.L. Fullerene nanomaterials inhibit phorbol myristate acetate-induced inflammation. Exp Dermatol 2009, 18:1079-1081.
4. Dugan L.L., Turetsky D.M., Du C., Lobner D., Wheeler M., Almli C.R., et al. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci USA 1997, 94:9434-9439.
5. Zhou Z., Lenk R., Dellinger A., MacFarland D., Kumar K., Wilson S.R., et al. Fullerene nanomaterials potentiate hair growth. Nanomedicine 2009, 5:202-207.
6. Schwartz L.B., Kepley C. Development of markers for human basophils and mast cells. J Allergy Clin Immunol 1994, 94:1231-1240.
7. Kepley C.L., Cohen N. Evidence for human mast cell nonreleaser phenotype. J Allergy Clin Immunol 2003, 112:457-459.
8. Kepley C.L. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Int Arch Allergy Immunol 2005, 138:29-39.
9. Kepley C.L., Youssef L., Andrews R.P., Wilson B.S., Oliver J.M. Multiple defects in Fc epsilon RI signaling in Syk-deficient nonreleaser basophils and IL-3-induced recovery of Syk expression and secretion. J Immunol 2000, 165:5913-5920.
10. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 1989, 37:1509-1515.
11. Sly L.M., Kalesnikoff J., Lam V., Wong D., Song C., Omeis S., et al. IgE-induced mast cell survival requires the prolonged generation of reactive oxygen species. J Immunol 2008, 181:3850-3860.
12. Swindle E.J., Metcalfe D.D. The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes. Immunol Rev 2007, 217:186-205.
13. Shimizu Y., Hendershot L.M. Organization of the functions and components of the endoplasmic reticulum. Adv Exp Med Biol 2007, 594:37-46.
14. Chirico F., Fumelli C., Marconi A., Tinari A., Straface E., Malorni W., et al. Carboxyfullerenes localize within mitochondria and prevent the UVB-induced intrinsic apoptotic pathway. Exp Dermatol 2007, 16:429-436.
15. Salonen E., Lin S., Reid M.L., Allegood M., Wang X., Rao A.M., et al. Real-time translocation of fullerene reveals cell contraction. Small 2008, 4:1986-1992.
16. Foley S., Crowley C., Smaihi M., Bonfils C., Erlanger B.F., Seta P., et al. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun 2002, 294:116-119.
17. 60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution electron microscopy and electron tomography. Acta Biomater 2006, 2:409-419.
18. Wong-Ekkabut J., Baoukina S., Triampo W., Tang I.M., Tieleman D.P., Monticelli L. Computer simulation study of fullerene translocation through lipid membranes. Nat Nanotechnol 2008, 3:363-368.
19. Sumizawa T., Igisu H. Suppression of acrylamide toxicity by carboxyfullerene in human neuroblastoma cells in vitro. Arch Toxicol 2009, 83:817-824.
20. Li W., Chen C., Ye C., Wei T., Zhao Y., Lao F., et al. The translocation of fullerenic nanoparticles into lysosome via the pathway of clathrin-mediated endocytosis. Nanotechnology 2008, 19:12-15.
21. 2+ and ROS. Front Biosci 2009, 14:1197-1218.
22. 60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem Biophys Res Commun 2000, 277:711-717.
23. Fumelli C., Marconi A., Salvioli S., Straface E., Malorni W., Offidani A.M., et al. Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosis. J Invest Dermatol 2000, 115:835-841.
24. Bakry R., Vallant R.M., Najam-ul-Haq M., Rainer M., Szabo Z., Huck C.W., et al. Medicinal applications of fullerenes. Int J Nanomed 2007, 2:639-649.
25. Djordjevic A., Bogdanovic G., Dobric S. Fullerenes in biomedicine. J BUON 2006, 11:391-404.
26. Jensen A.W., Wilson S.R., Schuster D.I. Biological applications of fullerenes. Bioorg Med Chem 1996, 4:767-779.